TCL Archive NCI Lung Cancer Mutation Consortium: Screening For Mutations Can Focus Therapy June 24, 2011
TCL Archive FCRC Recompetition To Be Split Into Two Major Contract, For Research And “Everything Else” September 5, 1980
TCL Archive Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial January 27, 2012